Eur Rev Med Pharmacol Sci 2017; 21 (14): 3185-3192
DOI:

Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway

B.-Q. Wu, Y. Cao, Z.-G. Bi

Department of Orthopedics, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. yuemingsongyyy@163.com


OBJECTIVE: Wnt/β-catenin signal pathway plays a role in regulating cell proliferation and apoptosis, and is correlated with tumor onset, progression and drug resistance. B-cell lymphoma 2 (Bcl-2) is an anti-apoptotic factor inducing tumor cell drug resistance. Wnt/β-catenin signal pathway can modulate Bcl-2 expression. This study established a cell model of drug resistance using adriamycin (ADM) treatment. Wnt/β-catenin signal pathway was intervened to discuss its role in drug resistance of osteosarcoma cells.

MATERIALS AND METHODS: Expression of β-catenin and Bcl-2 was compared between U2OS and hFOB1.19 cells. ADM resistant cell line U2OS/ADM was established for comparing β-catenin and Bcl-2 expression. Cell counting kit-8 (CCK-8) assay was used to test cell proliferation, followed by flow cytometry for apoptotic rate under ADM concentrations. U2OS/ADM cells were further treated with si-β-catenin and/or β-catenin inhibitor XAV939. β-catenin and Bcl-2 expression were measured, followed by CCK-8 and flow cytometry.

RESULTS: Comparing to hFOB1.19 cells, U2OS cells had significantly elevated β-catenin and Bcl-2 expression. U2OS/ADM cells had higher β-catenin and Bcl-2 expression than U2OS, plus lower ADM sensitivity and suppressed apoptotic rate. Transfection of si-β-catenin and XAV939 suppressed β-catenin and Bcl-2 expression, and significantly enhanced ADM sensitivity and ADM-induced apoptosis.

CONCLUSIONS: Up-regulation of β-catenin plays a role in potentiating expression and downstream anti-apoptotic factor Bcl-2, and in enhancing ADM resistance of osteosarcoma U2OS cells.

This article has been withdrawn. The Publisher apologizes for any inconvenience this may cause.

Free PDF Download

To cite this article

B.-Q. Wu, Y. Cao, Z.-G. Bi
Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway

Eur Rev Med Pharmacol Sci
Year: 2017
Vol. 21 - N. 14
Pages: 3185-3192
DOI: